Global Vectra Helicorp Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 27, 2025, 2:43 pm

Competitors of Global Vectra Helicorp Ltd

All Competitor Stocks of Global Vectra Helicorp Ltd

Quarterly Result

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for Global Vectra Helicorp Ltd based on the most recent figures (Dec 2023) and their trends compared to the previous period:

• For Sales, as of Dec 2023, the value is ₹129.59 Cr.. The value appears strong and on an upward trend. It has increased from ₹104.87 Cr. (Sep 2023) to ₹129.59 Cr., marking an increase of ₹24.72 Cr..
• For Expenses, as of Dec 2023, the value is ₹101.95 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹94.76 Cr. (Sep 2023) to ₹101.95 Cr., marking an increase of ₹7.19 Cr..
• For Operating Profit, as of Dec 2023, the value is ₹27.64 Cr.. The value appears strong and on an upward trend. It has increased from ₹10.11 Cr. (Sep 2023) to ₹27.64 Cr., marking an increase of ₹17.53 Cr..
• For OPM %, as of Dec 2023, the value is 21.33%. The value appears strong and on an upward trend. It has increased from 9.64% (Sep 2023) to 21.33%, marking an increase of 11.69%.
• For Other Income, as of Dec 2023, the value is ₹2.57 Cr.. The value appears to be declining and may need further review. It has decreased from ₹8.82 Cr. (Sep 2023) to ₹2.57 Cr., marking a decrease of ₹6.25 Cr..
• For Interest, as of Dec 2023, the value is ₹8.29 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from ₹10.01 Cr. (Sep 2023) to ₹8.29 Cr., marking a decrease of ₹1.72 Cr..
• For Depreciation, as of Dec 2023, the value is ₹16.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from ₹17.53 Cr. (Sep 2023) to ₹16.71 Cr., marking a decrease of ₹0.82 Cr..
• For Profit before tax, as of Dec 2023, the value is ₹5.21 Cr.. The value appears strong and on an upward trend. It has increased from ₹-8.61 Cr. (Sep 2023) to ₹5.21 Cr., marking an increase of ₹13.82 Cr..
• For Tax %, as of Dec 2023, the value is 35.12%. The value appears to be increasing, which may not be favorable. It has increased from 20.79% (Sep 2023) to 35.12%, marking an increase of 14.33%.
• For Net Profit, as of Dec 2023, the value is ₹3.38 Cr.. The value appears strong and on an upward trend. It has increased from ₹-6.82 Cr. (Sep 2023) to ₹3.38 Cr., marking an increase of ₹10.20 Cr..
• For EPS in Rs, as of Dec 2023, the value is ₹2.41. The value appears strong and on an upward trend. It has increased from ₹-4.87 (Sep 2023) to ₹2.41, marking an increase of ₹7.28.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: Unknown

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 11:41 pm

Below is a detailed analysis of the balance sheet data for Global Vectra Helicorp Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹14.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹-2.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹8.00 Cr. (Mar 2024) to ₹-2.00 Cr., marking a decrease of ₹10.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹457.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from ₹517.00 Cr. (Mar 2024) to ₹457.00 Cr., marking a decrease of ₹60.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹399.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹389.00 Cr. (Mar 2024) to ₹399.00 Cr., marking an increase of ₹10.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹868.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹928.00 Cr. (Mar 2024) to ₹868.00 Cr., marking a decrease of ₹60.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹460.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹483.00 Cr. (Mar 2024) to ₹460.00 Cr., marking a decrease of ₹23.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
• For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹408.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹445.00 Cr. (Mar 2024) to ₹408.00 Cr., marking a decrease of ₹37.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹868.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹928.00 Cr. (Mar 2024) to ₹868.00 Cr., marking a decrease of ₹60.00 Cr..

However, the Borrowings (₹457.00 Cr.) are higher than the Reserves (₹-2.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Global Vectra Helicorp Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 5. It has increased from -11.88 (Mar 23) to 0.86, marking an increase of 12.74.
• For Diluted EPS (Rs.), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 5. It has increased from -11.88 (Mar 23) to 0.86, marking an increase of 12.74.
• For Cash EPS (Rs.), as of Mar 24, the value is 52.11. This value is within the healthy range. It has increased from 41.99 (Mar 23) to 52.11, marking an increase of 10.12.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 15.58. It has decreased from 20.07 (Mar 23) to 15.58, marking a decrease of 4.49.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 15.58. It has decreased from 20.07 (Mar 23) to 15.58, marking a decrease of 4.49.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 359.09. It has increased from 293.65 (Mar 23) to 359.09, marking an increase of 65.44.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 76.93. This value is within the healthy range. It has increased from 55.64 (Mar 23) to 76.93, marking an increase of 21.29.
• For PBIT / Share (Rs.), as of Mar 24, the value is 25.68. This value is within the healthy range. It has increased from 1.78 (Mar 23) to 25.68, marking an increase of 23.90.
• For PBT / Share (Rs.), as of Mar 24, the value is 1.67. This value is within the healthy range. It has increased from -13.15 (Mar 23) to 1.67, marking an increase of 14.82.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 2. It has increased from -11.88 (Mar 23) to 0.86, marking an increase of 12.74.
• For PBDIT Margin (%), as of Mar 24, the value is 21.42. This value is within the healthy range. It has increased from 18.94 (Mar 23) to 21.42, marking an increase of 2.48.
• For PBIT Margin (%), as of Mar 24, the value is 7.15. This value is below the healthy minimum of 10. It has increased from 0.60 (Mar 23) to 7.15, marking an increase of 6.55.
• For PBT Margin (%), as of Mar 24, the value is 0.46. This value is below the healthy minimum of 10. It has increased from -4.47 (Mar 23) to 0.46, marking an increase of 4.93.
• For Net Profit Margin (%), as of Mar 24, the value is 0.23. This value is below the healthy minimum of 5. It has increased from -4.04 (Mar 23) to 0.23, marking an increase of 4.27.
• For Return on Networth / Equity (%), as of Mar 24, the value is 5.53. This value is below the healthy minimum of 15. It has increased from -59.17 (Mar 23) to 5.53, marking an increase of 64.70.
• For Return on Capital Employeed (%), as of Mar 24, the value is 8.48. This value is below the healthy minimum of 10. It has increased from 0.72 (Mar 23) to 8.48, marking an increase of 7.76.
• For Return On Assets (%), as of Mar 24, the value is 0.12. This value is below the healthy minimum of 5. It has increased from -2.16 (Mar 23) to 0.12, marking an increase of 2.28.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.08. This value exceeds the healthy maximum of 1. It has increased from 1.04 (Mar 23) to 1.08, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.91. This value exceeds the healthy maximum of 1. It has increased from 1.55 (Mar 23) to 1.91, marking an increase of 0.36.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.59. It has increased from 0.57 (Mar 23) to 0.59, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 24, the value is 0.51. This value is below the healthy minimum of 1.5. It has increased from 0.50 (Mar 23) to 0.51, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 24, the value is 0.45. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 23) to 0.45, marking an increase of 0.01.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.20. This value is within the healthy range. It has decreased from 3.73 (Mar 23) to 3.20, marking a decrease of 0.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.04. This value is below the healthy minimum of 3. It has increased from 0.20 (Mar 23) to 1.04, marking an increase of 0.84.
• For Enterprise Value (Cr.), as of Mar 24, the value is 196.31. It has increased from 101.61 (Mar 23) to 196.31, marking an increase of 94.70.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.39. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 23) to 0.39, marking an increase of 0.15.
• For EV / EBITDA (X), as of Mar 24, the value is 1.82. This value is below the healthy minimum of 5. It has increased from 1.30 (Mar 23) to 1.82, marking an increase of 0.52.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 23) to 0.34, marking an increase of 0.17.
• For Price / BV (X), as of Mar 24, the value is 7.90. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 23) to 7.90, marking an increase of 5.29.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.34. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 23) to 0.34, marking an increase of 0.17.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.22 (Mar 23) to 0.01, marking an increase of 0.23.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness